Biogen
BIIB
BIIB
986 hedge funds and large institutions have $37.1B invested in Biogen in 2019 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 319 increasing their positions, 415 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
986
Holders Change
-23
Holders Change %
-2.28%
% of All Funds
21.66%
Holding in Top 10
17
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+6.25%
% of All Funds
0.37%
New
77
Increased
319
Reduced
415
Closed
94
Calls
$1.07B
Puts
$1.38B
Net Calls
-$312M
Net Calls Change
+$6.8M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$405M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$146M |
| 3 |
HM
HealthCor Management
New York
|
+$83.1M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$81.5M |
| 5 |
BS
Banco Santander
Madrid,
Spain
|
+$79.1M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$192M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$168M |
| 3 |
BlackRock
New York
|
-$134M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$124M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$103M |
